A Phase II study of flavopiridol [alvocidib] in patients with relapsed and refractory multiple myeloma
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2013
At a glance
- Drugs Alvocidib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 30 Oct 2007 Status changed from in progress to completed.
- 25 Sep 2005 New trial record.